A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas

ESMO Open · Elsevier

Аннотация

Publication date: November 2026 Source: ESMO Open, Volume 11, Issue 11 Author(s): W.N. William, L. Feng, M.S. Kies, S. Ahmed, G.R. Blumenschein, B.S. Glisson, E. Massarelli, F.M. Johnson, C. Lu, X. Le, L.P. Kowalski, E.S. Kim

Читать у издателя →

Похожие статьи